Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, Castaneda S, Cornelius LA, Das J, Doweyko AM, Fairchild C, Hunt JT, Inigo I, Johnston K, Kamath A, Kan D, Klei H, Marathe P, Pang S, Peterson R, Pitt S, Schieven GL, Schmidt RJ, Tokarski J, Wen ML, Wityak J, Borzilleri RM.

J Med Chem. 2004 Dec 30;47(27):6658-61.

PMID:
15615512
2.

An update on dual Src/Abl inhibitors.

Musumeci F, Schenone S, Brullo C, Botta M.

Future Med Chem. 2012 Apr;4(6):799-822. doi: 10.4155/fmc.12.29. Review.

PMID:
22530642
3.

Bosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia.

Keller G, Schafhausen P, Brummendorf TH.

Expert Rev Hematol. 2009 Oct;2(5):489-97. doi: 10.1586/ehm.09.42. Review.

PMID:
21083014
5.

Targeted drugs in chronic myeloid leukemia.

Gora-Tybor J, Robak T.

Curr Med Chem. 2008;15(29):3036-51. Review.

PMID:
19075651
6.

Novel dual Src/Abl inhibitors for hematologic and solid malignancies.

Schenone S, Brullo C, Musumeci F, Botta M.

Expert Opin Investig Drugs. 2010 Aug;19(8):931-45. doi: 10.1517/13543784.2010.499898. Review.

PMID:
20557276
7.

Dual tyrosine kinase inhibitors in chronic myeloid leukemia.

Martinelli G, Soverini S, Rosti G, Baccarani M.

Leukemia. 2005 Nov;19(11):1872-9. Review.

PMID:
16179913
8.

Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia.

Boschelli F, Arndt K, Gambacorti-Passerini C.

Eur J Cancer. 2010 Jul;46(10):1781-9. doi: 10.1016/j.ejca.2010.02.032. Review.

PMID:
20399641
9.

New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check.

O'Hare T, Eide CA, Deininger MW.

Expert Opin Investig Drugs. 2008 Jun;17(6):865-78. doi: 10.1517/13543784.17.6.865 . Review.

PMID:
18491988
10.

[18F]-N-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-fluoroethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2008 Aug 30 [updated 2008 Oct 15].

Items per page

Supplemental Content

Write to the Help Desk